Sunday, June 18, 2023 5:59:18 AM
Oh! For the love of Linda!
Only one has bought any meaningful quantity close to the market for the eleven years I have owned them.
JJ
That is it. When attackers came after Musk he bought shares. He went public. Took accountability when they came after his methods. Silence and poor plans and execution for NWBO. Many weeks to get the AACR article taken down after May 10 allowing others to form a narrative.
The discussion here is getting as difficult as the management.
I am done today. Keep it up for Linda and this situation because poor execution allowed the narrative and then illegal trading took place. Ok. She will win the lawsuit. I would rather not be in one and have had her issue 10 million shares at $4 to $5 after that May 10 day. The following day she should have been on cable showing peer reviewed GBM and rGBM data and talking about manufacturing capabilities.
Nothing is ever her fault. Where is a corporate raider when you need one!
Only one has bought any meaningful quantity close to the market for the eleven years I have owned them.
JJ
That is it. When attackers came after Musk he bought shares. He went public. Took accountability when they came after his methods. Silence and poor plans and execution for NWBO. Many weeks to get the AACR article taken down after May 10 allowing others to form a narrative.
The discussion here is getting as difficult as the management.
I am done today. Keep it up for Linda and this situation because poor execution allowed the narrative and then illegal trading took place. Ok. She will win the lawsuit. I would rather not be in one and have had her issue 10 million shares at $4 to $5 after that May 10 day. The following day she should have been on cable showing peer reviewed GBM and rGBM data and talking about manufacturing capabilities.
Nothing is ever her fault. Where is a corporate raider when you need one!
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
